126 related articles for article (PubMed ID: 36880383)
1. Mixed insulin can improve control of prednisolone-induced hyperglycaemia.
Scholes G; Ng E; Bach LA; Sztal-Mazer S
Intern Med J; 2023 Dec; 53(12):2264-2269. PubMed ID: 36880383
[TBL] [Abstract][Full Text] [Related]
2. Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study.
Radhakutty A; Stranks JL; Mangelsdorf BL; Drake SM; Roberts GW; Zimmermann AT; Stranks SN; Thompson CH; Burt MG
Diabetes Obes Metab; 2017 Apr; 19(4):571-578. PubMed ID: 27995731
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients.
Burt MG; Drake SM; Aguilar-Loza NR; Esterman A; Stranks SN; Roberts GW
Intern Med J; 2015 Mar; 45(3):261-6. PubMed ID: 25565560
[TBL] [Abstract][Full Text] [Related]
4. MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia.
Radhakutty A; Burt MG
Eur J Endocrinol; 2018 Oct; 179(4):R207-R218. PubMed ID: 30299889
[TBL] [Abstract][Full Text] [Related]
5. Clinical determinants of insulin requirements during treatment of prednisolone-induced hyperglycaemia.
Chen AX; Radhakutty A; Zimmermann A; Stranks SN; Thompson CH; Burt MG
Diabetes Res Clin Pract; 2023 Mar; 197():110557. PubMed ID: 36736733
[TBL] [Abstract][Full Text] [Related]
6. A retrospective audit of insulin infusion management involving a locally developed dynamic insulin infusion guideline in a tertiary ICU.
Breeding J; Welch S; Buscher H; Nair P; Frost C; Newman S; Whittam S
Aust Crit Care; 2015 Aug; 28(3):149-59. PubMed ID: 25092627
[TBL] [Abstract][Full Text] [Related]
7. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial.
Kaneko S; Chow F; Choi DS; Taneda S; Hirao K; Park Y; Andersen TH; Gall MA; Christiansen JS;
Diabetes Res Clin Pract; 2015 Jan; 107(1):139-47. PubMed ID: 25498130
[TBL] [Abstract][Full Text] [Related]
8. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
Choudhary P; Davies C; Emery CJ; Heller SR
Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
[TBL] [Abstract][Full Text] [Related]
9. [Comparison on the efficacy of biphasic insulin aspart 30 and premixed human insulin 30/70 through continuous glucose monitoring system].
Chen SF; Li H
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Aug; 32(8):827-9. PubMed ID: 22093477
[TBL] [Abstract][Full Text] [Related]
10. Basal-bolus insulin versus sliding-scale insulin for inpatient glycaemic control: a clinical practice comparison.
Roberts GW; Aguilar-Loza N; Esterman A; Burt MG; Stranks SN
Med J Aust; 2012 Mar; 196(4):266-9. PubMed ID: 22409694
[TBL] [Abstract][Full Text] [Related]
11. Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.
McSorley PT; Bell PM; Jacobsen LV; Kristensen A; Lindholm A
Clin Ther; 2002 Apr; 24(4):530-9. PubMed ID: 12017398
[TBL] [Abstract][Full Text] [Related]
12. Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Jan; 23(1):46-52. PubMed ID: 16409565
[TBL] [Abstract][Full Text] [Related]
13. Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.
Franek E; Haluzík M; Canecki Varžić S; Sargin M; Macura S; Zacho J; Christiansen JS
Diabet Med; 2016 Apr; 33(4):497-505. PubMed ID: 26435365
[TBL] [Abstract][Full Text] [Related]
14. Divided dosing reduces prednisolone-induced hyperglycaemia and glycaemic variability: a randomized trial after kidney transplantation.
Yates CJ; Fourlanos S; Colman PG; Cohney SJ
Nephrol Dial Transplant; 2014 Mar; 29(3):698-705. PubMed ID: 24009292
[TBL] [Abstract][Full Text] [Related]
15. A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial.
Macrae D; Grieve R; Allen E; Sadique Z; Betts H; Morris K; Pappachan VJ; Parslow R; Tasker RC; Baines P; Broadhead M; Duthie ML; Fortune PM; Inwald D; McMaster P; Peters MJ; Schindler M; Guerriero C; Piercy D; Slavik Z; Snowdon C; Van Dyck L; Elbourne D
Health Technol Assess; 2014 Apr; 18(26):1-210. PubMed ID: 24780450
[TBL] [Abstract][Full Text] [Related]
16. HIGH-DOSE GLUCOCORTICOID TREATMENT DOES NOT INDUCE SEVERE HYPERGLYCEMIA IN YOUNG PATIENTS WITH AUTOIMMUNE DISEASES BY CGMS.
Zhou Y; Zhao Y; Yuan T; Jiang N; Dong Y; Yang Y; Wang L; Zhao J; Min L; Zhao W
Endocr Pract; 2018 Jan; 24(1):60-68. PubMed ID: 29106815
[TBL] [Abstract][Full Text] [Related]
17. An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia following betamethasone administration in women with gestational diabetes.
Rowe CW; Putt E; Brentnall O; Gebuehr A; Allabyrne J; Woods A; Wynne K
Diabet Med; 2019 Feb; 36(2):228-236. PubMed ID: 30443983
[TBL] [Abstract][Full Text] [Related]
18. Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children.
Kinmonth AL; Baum JD
Br Med J; 1980 Mar; 280(6214):604-6. PubMed ID: 6989436
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
[TBL] [Abstract][Full Text] [Related]
20. Computer-determined dosage of insulin in the management of neonatal hyperglycaemia (HINT2): protocol of a randomised controlled trial.
Alsweiler J; Williamson K; Bloomfield F; Chase G; Harding J
BMJ Open; 2017 Mar; 7(3):e012982. PubMed ID: 28264826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
